ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 137 filers reported holding ARRAY BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $3,074,000 | +33.1% | 343,900 | +30.9% | 0.19% | +2.1% |
| Q4 2016 | $2,309,000 | -61.0% | 262,700 | -70.1% | 0.19% | -60.4% |
| Q3 2016 | $5,925,000 | +335.7% | 877,800 | +129.7% | 0.48% | +278.0% |
| Q2 2016 | $1,360,000 | -16.3% | 382,200 | -30.6% | 0.13% | -22.6% |
| Q1 2016 | $1,625,000 | +1666.3% | 550,900 | +2415.5% | 0.16% | +1266.7% |
| Q4 2015 | $92,000 | -91.9% | 21,900 | -91.2% | 0.01% | -91.8% |
| Q3 2015 | $1,133,000 | +128.4% | 249,200 | +261.2% | 0.15% | +113.0% |
| Q2 2015 | $496,000 | – | 69,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |